Wearable Cardioverter Defibrillators Market Players:
- ZOLL Medical Corporation
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Element Science Inc.
- Medtronic plc
- Kestra Medical Technologies, Inc.
- Abbott
- Boston Scientific Corporation
- LivaNova plc
- Koninklijke Philips N.V.
- Nihon Kohden Corporation
- General Electric Company.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of wearable cardioverter defibrillators is assessed at USD 298.06 million.
The global wearable cardioverter defibrillators market size crossed USD 274.58 million in 2025 and is likely to register a CAGR of over 9.5%, exceeding USD 680.47 million revenue by 2035.
By 2035, North America is anticipated to command a 38% share of the wearable cardioverter defibrillators market, supported by expanded R&D capabilities and increasing healthcare expenditure owing to advanced device innovation.
Key players in the market include ZOLL Medical Corporation, Element Science Inc., Medtronic plc, Kestra Medical Technologies, Inc., Abbott, Boston Scientific Corporation, LivaNova plc, Koninklijke Philips N.V., Nihon Kohden Corporation and General Electric Company.
